SUPERIMPOSITION OF PET IMAGES USING F-18 FLUORODEOXYGLUCOSE WITH MAGNETIC-RESONANCE IMAGES IN PATIENTS WITH PANCREATIC-CARCINOMA

被引：11

作者：

BENYOUNES, H ^{[1
]}

SMITH, FW ^{[1
]}

CAMPBELL, C ^{[1
]}

EVANS, NTS ^{[1
]}

NORTON, MY ^{[1
]}

MIKECZ, P ^{[1
]}

HEYS, SD ^{[1
]}

BRUCE, D ^{[1
]}

EREMIN, O ^{[1
]}

SHARP, PF ^{[1
]}

机构：

[1] ABERDEEN ROYAL INFIRM,NHS TRUST,DEPT NUCL MED,ABERDEEN AB9 2ZD,SCOTLAND

来源：

NUCLEAR MEDICINE COMMUNICATIONS | 1995年 / 16卷 / 07期

关键词：

D O I：

10.1097/00006231-199507000-00009

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Six patients with histologically proven adenocarcinoma of the pancreas were studied using 2-deoxy-2-[F-18]-fluoro-D-glucose (F-18-FDG) using positron emission tomography (PET), and magnetic resonance imaging (MRI). In all six cases there was avid accumulation of F-18-FDG within the pancreatic tumour and clear visualization of the tumour on the MRI images. Delineation of the tumours was aided by superimposition of the images from the two imaging methods, which was achieved by using a system of surface markers.

引用

页码：575 / 580

页数：6

共 17 条

[1]

Freely P.C., Marks W., Et al., Pancreatic ductal adenocarcinoma: Diagnosis and staging with dynamic CT, Radiology, 166, pp. 125-133, (1988)

[2]

Yankaskas B.C., Staab E.V., Rudnick S.A., Fletcher R.H., The radiologic diagnosis of pancreatic cancer the effect of new imaging techniques, Invest Radiol, 20, pp. 73-78, (1985)

[3]

Connoly M.M., Dawson P.J., Michaelassi F., Moossa A.R., Lowenstein F., Survival of 1001 patients with carcinoma of the pancreas, Ann Surg, 206, pp. 366-370, (1987)

[4]

Stark D.D., Biliary system, pancreas, spleen and alimentary tract, Magnetic Resonance Imaging, pp. 1060-1139, (1988)

[5]

Strauss L., Clorius J.H., Schlag P., Lehner B., Kimmig B., Engenhart R., Marin-Grez M., Helus F., Oberdorfer F., Smidlin P., Van Kiack G., Recurrence of colorectal tumors: PET evaluation, Radiology, 170, pp. 329-332, (1989)

[6]

Smith F.W., Heys S.D., Evans N., Roeda D., Gvozdanovic D., Eremin O., Mallard R., Pattern of 2-deoxy-2-[18F]-fluoro D-glucose accumulation in liver tumours, Primary, Metastatic and after Chemotherapy. Nucl Med Commun, 13, pp. 193-195, (1992)

[7]

Kubota K., Matsuzawa T., Fujiwara T., Ito M., Hatazawa J., Isiwata K., Iwata R., Ido T., Differential diagnosis of lung tumor with positron emission tomography, A Prospective Study, J Nucl Med, 31, pp. 1927-1933, (1990)

[8]

Tse N.Y., Hoh C.K., Hawkins R.A., Zinner M.J., Dahlbom M., Choi Y., Maddahi J., Bruncardi C., Phelps M.E., Glaspy J.A., The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease, Ann Surg, 216, pp. 27-34, (1992)

[9]

Bares R., Klever P., Hellwig D., Hauptmann S., Fass J., Hambuechen U., Zopp L., Buell U., Schumpelick V., Pancrea¬tic cancer detected by positron emission tomography with 18F-labelled deoxyglucose, Method and First Results. Nucl Med Commun, 14, pp. 596-601, (1993)

[10]

Bares R., Klever P., Hauptmann S., Hellwig D., Fass J., Cremerius U., Schumpelick V., Mittermayer C., Buell U., F- 18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer, Radiology, 192, pp. 79-86, (1994)

← 1 2 →